Phospholipids are major components of
plasma membrane and organelle membranes that maintain the integrity of the cell
or organelles by creating a semi-impermeable barrier from their outside environment.
In normal cells, phospholipids are asymmetrically distributed in inner and
outer leaflets of plasma membrane, with phosphatidylcholine
(PC) and sphingomyelin (SM) predominantly in the
outside leaflet and phosphatidylserine (PS) and phosphatidylethanolamine (PE) in the inner leaflet of
plasma membrane. Phospholipid asymmetry is also seen with membrane
organelles. More and more studies have indicated that phospholipid
asymmetry may play critical roles in many important biological and cellular
processes. For example, phospholipid asymmetry helps
target proteins to appropriate subcellular sites or
organelles for specific cellular processes (e.g. organelle fusion/division or
apoptosis), maintain biophysical properties of specific membranes, sustain cell
shape, facilitate membrane vesicle trafficking/fusion/budding, regulate
activities of membrane proteins, and transduce
intracellular signals. On the other hand, alteration of phospholipid
asymmetry (for example, the externalization of PS by a cell) can also play
important roles in activating cellular or biological processes such as blood
coagulation, recognition and removal of apoptotic cells, cytokinesis,
and cell fusion. It is very likely that phospholipid
asymmetry or alteration of phospholipid asymmetry can
have other crucial cellular functions that have yet to be discovered and
characterized. It has been suggested that an energy-dependent, active phospholipid transbilayer
movement is needed to establish and maintain the phospholipid
asymmetry. In addition, constant and dynamic membrane trafficking between
plasma membrane and organelles (endocytosis, exocytosis, vesicle fusion and division) and modifications
or hydrolysis of phospholipids by lipid enzymes such as phospholipases
also contribute to the generation or alteration of phospholipid
asymmetry. In my laboratory, we are interested in addressing three fundamental
questions regarding phospholipid asymmetry using a
combination of genetic, functional genomic, cell biological, and biochemical
approaches
1) Why does a cell need to generate and
maintain phospholipid asymmetry, and in certain
situations, alter this asymmetry?
2) What is the molecular machinery or
network that generates and maintains the phospholipid
asymmetry?
3) How does alteration of phospholipid asymmetry impact the functions and the
activities of a cell?
Related
Publications:
Wang, X.C., Wu, Y.C., Fadok, V., Lee, M.C., Gengyo-Ando, K., Cheng, L.C., Ledwich, D., Hsu, P.K., Chen, J.Y., Chou, B.K., Henson, P., Mitani, S., and Xue, D. (2003). Cell Corpse Engulfment Mediated by C. elegans Phosphatidylserine Receptor Through CED-5 and CED-12. Science 302, 1563-1566. (Abstract and PDF). Science Perspectives (PDF) and ScienceÕs STKE review (PDF)
Fadeel, B. and Xue, D. (2005). PS externalization: from corpse clearance to drug delivery. Cell Death Differentiation, 13: 360-362. (PDF)
Wang, X.C., Wang, J., Gengyo-Ando, K., Gu, L.C., Sun, C.L., Yang, C.L., Shi, Y., Kobayashi, T., Shi, Y.G., Mitani, S., Xie, X.S., and Xue, D. (2007). "C. elegans mitochondrial factor WAH-1 promotes phosphatidylserine externalization in apoptotic cells through phospholipid scramblase SCRM-1". Nature Cell Biology 9, 541-549. (Abstract and PDF). Nature Reviews Molecular Cell Biology (PDF)
Darland-Ransom, M., Wang, X.C., Sun, C.L., Mapes, J., Gengyo-Ando, K., Mitani, S. and Xue, D. (2008). Role of C. elegans
TAT-1 protein in maintaining plasma membrane phosphatidylserine
asymmetry. Science
320, 528-531. (Abstract
and PDF). Science
Perspectives (PDF)